) revealed a first-quarter earnings beat on Thursday, posting revenue of $12.68 billion, a 19% year-over-year gain. In addition, the pharmaceutical giant has reiterated its full-year guidance by claiming its"core EPS is expected to increase by a low double-digit to low teens percentage." To keep that guidance, the company bolstered its drug production, particularly in China, as uncertainty caused by geopolitical conflicts gave cause for concern.
Investors are ramping up their exits from Cathie Wood's ARK after an epic 72% decline in her flagship fund It paid off nicely to dump stocks nearly a year before the dot-com and housing bubbles burst, B. Riley's Paul Dietrich said. -- After years of fits and starts, Venezuela is setting the stage for one of the largest and most complex debt restructurings in decades — unwinding a $154 billion web of defaulted bonds, loans and legal judgments owed to creditors from Wall Street to Russia.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: globeandmail - 🏆 5. / 92 Read more »
Source: globebusiness - 🏆 31. / 66 Read more »